PharVision Advisers’s Genie Energy GNE Stock Holding History

PharVision Advisers’s Portfolio GNE Stock Details GNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,628	Closed	-$188K	–	327
2025 Q4	$188K	Sell	13,628 -380	-3%	-$5.59K	0.1%	584
2025 Q3	$209K	Buy	+14,008	New	+$251K	0.12%	483

Other funds holding GNE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCTC

Sanibel Captiva Trust Company Sanibel, Florida $4.02B AUM 34.36% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

PharVision Advisers's GNE Position: Q1 2026 in Review

PharVision Advisers sold out of Genie Energy (GNE) in Q1 2026, closing a stake of 13,628 shares — an estimated $188K sold.

PharVision Advisers first reported a position in GNE in Q3 2025 and held it in 2 quarters. The position peaked at $209K in Q3 2025. 116 funds tracked by Wall St. Rank hold GNE as of Q1 2026.

PharVision Advisers reported no remaining Genie Energy position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 13,628 Genie Energy shares in Q1 2026, an estimated $188K.
PharVision Advisers first reported a position in Genie Energy in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Genie Energy position peaked at $209K in Q3 2025.
116 funds tracked by Wall St. Rank held Genie Energy as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.